Claritev

Claritev Net Debt / EBITDA

The Net Debt to EBITDA of Claritev (CTEV) as of Nov 4, 2026 is 9.33. In the previous year, Net Debt to EBITDA was -4.45 — a change of -309.69% (higher).

Net Debt / EBITDA

9.33

YoY

-309.69%

Last updated:

Net Debt to EBITDA of Claritev is 2025 9.33 . Net Debt to EBITDA of Claritev was 2024 -4.45 . It decreases by -309.69% higher compared to the previous year.

The Claritev Net Debt / EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt / EBITDA
Date
Net Debt / EBITDA
Jan 1, 2019
7.09 USD
Jan 1, 2020
16.90 USD
Jan 1, 2021
5.95 USD
Jan 1, 2022
29.78 USD
Jan 1, 2023
7.69 USD
Jan 1, 2024
-4.45 USD
Jan 1, 2025
9.33 USD
The Claritev Net Debt / EBITDA history
YEARNet Debt / EBITDAYoY
9.33-309.69%
-4.45-157.90%
7.69-74.18%
29.78+400.57%
5.95-64.79%
16.90+138.30%
7.09—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Claritev Stock analysis

What does Claritev do? Claritev Corp generates revenue through its Analytics-Based Services, which uses data-driven algorithms to detect over-charges in healthcare claims and negotiate fair reimbursement for out-of-network costs. The company also offers Network-Based Services, including contracting discounts with providers to form independent PPOs and providing outsourced network development and management. Payment and Revenue Integrity Services identifies improper charges before or after claims are paid, while its SaaS platform delivers data analytics for healthcare cost management. Clients include healthcare providers, insurers, and employers seeking cost efficiency in medical billing and reimbursement processes. Claritev Corp's products target segments such as healthcare cost management, network development, and revenue integrity. The company's SaaS platform integrates descriptive, predictive, and prescriptive analytics to process data from multiple sources. Its services are designed to reduce overpayments and underpayments in healthcare claims, appealing to organizations focused on optimizing financial outcomes in medical billing. The business model relies on selling these integrated services to healthcare organizations, with a focus on data-driven solutions for cost control. Analytics-Based Services and Payment and Revenue Integrity Services directly address claim accuracy and reimbursement fairness, while Network-Based Services create cost-saving provider networks. The SaaS platform serves as the technological backbone for all offerings, enabling scalable data processing and insights. Claritev is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Claritev stock

Net Debt to EBITDA of Claritev is 9.33 in 2025.

Net Debt to EBITDA of Claritev changed from -4.45 to 9.33, representing a -309.69% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to EBITDA Claritev since 2006 – with annual values, charts, and detailed analysis.

Net Debt/EBITDA measures how many years it would take to repay all debt using EBITDA. Lower ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to EBITDA's Claritev with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Claritev

All Key Metrics — Claritev